Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1869-6961
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes ; volume:12 ; number:9 ; day:22 ; month:7 ; year:2021 ; pages:2371-2386 ; date:9.2021
Diabetes therapy ; 12, Heft 9 (22.7.2021), 2371-2386, 9.2021

Creator
Hero, Christel
Karlsson, Sofia Axia
Franzén, Stefan
Svensson, Ann-Marie
Miftaraj, Mervete
Gudbjörnsdottír, Soffia
Andersson-Sundell, Karolina
Eliasson, Björn
Eeg-Olofsson, Katarina
Contributor
SpringerLink (Online service)

DOI
10.1007/s13300-021-01115-w
URN
urn:nbn:de:101:1-2021110918302475255038
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Hero, Christel
  • Karlsson, Sofia Axia
  • Franzén, Stefan
  • Svensson, Ann-Marie
  • Miftaraj, Mervete
  • Gudbjörnsdottír, Soffia
  • Andersson-Sundell, Karolina
  • Eliasson, Björn
  • Eeg-Olofsson, Katarina
  • SpringerLink (Online service)

Other Objects (12)

Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

Initial non-adherence to lipid-lowering medication: a systematic literature review

Initial non-adherence to lipid-lowering medication: a systematic literature review

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe

Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study

Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study

Glycaemic Effects of Non-statin Lipid-Lowering Therapies

Glycaemic Effects of Non-statin Lipid-Lowering Therapies

Lipid-lowering properties of protein-rich mucuna product

Lipid-lowering properties of protein-rich mucuna product

Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence

Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence

Ezetimibe as lipid-lowering therapy for patients receiving HAART

Ezetimibe as lipid-lowering therapy for patients receiving HAART

Nicotinic acid: a lipid-lowering agent with unrealized potential

Nicotinic acid: a lipid-lowering agent with unrealized potential

Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons

Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention

Related objects